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Summary 
 
This technical report outlines the technical issues related to the estimation of measurement 
uncertainty (MU) involved in the GMO sector. In particular it gives guidance to GMO testing 
laboratories how to estimate the analytical variability of quantitative analytical results 
obtained by real-time PCR. This guidance document has been written on request of the 
European Network of GMO Laboratories (ENGL) as a follow-up of a workshop on 
Measurement Uncertainty in the GMO sector organised by the Institute for Reference 
Materials and Measurements (IRMM), Geel, Belgium and held on 05.07.2005.  
 
It is recognised that in order to be able to judge if an analytical results exceeds a threshold; the 
MU must be estimated and reported together with the measurement result. Enforcement 
Authorities shall therefore estimate the MU associated with an analytical result and use it to 
decide whether an analytical result falls within the specification of food and feed control. The 
value obtained by subtracting the expanded uncertainty from the reported concentration is 
used to assess compliance. Only if this value is greater than the legal threshold, it is sure 
'beyond reasonable doubt' that the sample concentration of the analyte is beyond what is 
permissible. 
 
Two selected approaches for the estimation of MU are presented in detail; references to 
alternative approaches are given. The first approach presented in detail is using data from 
collaborative trial in combination with in-house quality control data for the estimation of MU. 
Prerequisites for the use of such collaborative trial data are outlined. In case no suitable 
collaborative trial data are available, an alternative approach for the estimation of MU, using 
data obtained on within-laboratory samples, is presented.  
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Glossary 
 
AOAC  Association of Official Analytical Chemists 
c  sample concentration 
CRL  Community Reference Laboratory 
CRM  Certified Reference Material 
CTAB  cetyltrimethylammonium bromide 
Ct-value number of PCR cycles to pass a set threshold 
DG SANCO Directorate-General Health and Consumer Protection 
DNA  deoxyribonucleic acid 
ENGL  European Network of GMO laboratories 
ERM®  European Reference Material® 
EU  European Union 
EURACHEM Network of analytical chemistry organisations in Europe 
GM  genetically modified 
GMO  genetically modified organism 
GUM  Guide to the Expression of Uncertainty in Measurement 
IQC  internal quality control 
IRMM  Institute for Reference Materials and Measurements 
ISO  International Standards Organisation 
IEC   International Electrotechnical Commission 
IUPAC  International Union of Pure and Applied Chemistry 
LC  critical level 
LOD  limit of detection 
LOQ   limit of quantification 
m/m  mass fraction 
MU  measurement uncertainty 
n  number of independent measurements 
NIB  National Institute of Biology 
NMKL   Nordic Committee on Food Analysis 
PCR  polymerase chain reaction 
RSU  relative standard uncertainty 
RRS  Roundup Ready® soya 
TVP  texturised vegetable protein 
U  expanded uncertainty 
u  standard uncertainty 
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1 Introduction 
 
It has been recognised that there are a number of actions that may be taken by those 
responsible for the enforcement of EU legislation which directly affect decisions as to 
whether a sample, or a lot from which a sample is taken, is in compliance with EU legislation. 
 
It must be appreciated that the enforcement of any requirement in EU legislation which is 
based on measurement results depends on the analytical methods and their measurement 
uncertainties (MUs). Without common and uniform criteria for evaluation and interpretation 
of the MU, different Member States will make different judgements as to whether any 
particular lot is in compliance with its EU specification. 
 
After a workshop on MU in the GMO sector organised and held on 05.07.2005 at the Institute 
for Reference Materials and Measurements (IRMM) in Geel, Belgium, a task force of the 
European Network of GMO Laboratories (ENGL) has been formed to outline the related 
scientific and technical issues. This resulting technical report provides recommendations and 
gives guidance to the Enforcement Authorities in Member States on procedures to be adopted 
that reduce the possibility of Member States taking differing views as to whether a particular 
sample is in compliance with any particular EU specification. 
 
This report focuses on analytical issues only. In particular it considers the treatment of 
analytical uncertainty (normally known as the MU) in the interpretation of a specification. It 
is mainly concerned with quantitative analytical results. This report is written in a form such 
that the complex issues involved can be readily appreciated by all. In particular, it: 
 
• sets out the issues; 
• gives recommendations for consideration by the Enforcement Authorities of the Member 
States; and 
• gives a series of technical Annexes to aid practitioners in estimating their MUs. 
 
This report further develops the general DG SANCO report 'On the relationship between 
analytical results, measurement uncertainty, recovery factors and the provisions of EU food 
and feed legislation, with particular reference to community legislation concerning 
contaminants in food and undesirable substances in feed' [1] for application in the GMO 
sector. 
 
It should be noted that the MU estimation as such is independent from the unit of 
measurement. Independent if mass fractions (m/m) or copy number ratios are used, the 
estimation is carried out in the same way. Attention needs to be paid, that the unit of 
measurement is not changed during its uncertainty estimation. However, the user should pay 
extra attention when using percent as measurements unit as these absolute values can easily 
be mixed-up with relative values given as well in percent. 
 
                                                 
[1] DG Health and Consumer Protection: Report to the Standing Committee on the Food Chain and Animal 
Health on the relationship between analytical results, the measurement uncertainty, recovery factors and the 
provisions in EU food and feed legislation with particular focus on the community legislation, 
http://ec.europa.eu/food/food/chemicalsafety/contaminants/report-sampling_analysis_2004_en.pdf 
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1.1 Purpose 
 
The requirements and recommendations made in this document are aimed at providing help to 
the practitioner dealing with samples under Regulation (EC) No 882/2004 'on official controls 
performed to ensure the verification of compliance with feed and food law' [2] and 
specifically under Regulation (EC) No 1829/2003 on 'genetically modified food and feed' [3] 
and Regulation (EC) No 1830/2003 concerning the traceability and labelling of genetically 
modified organisms and the traceability of food and feed products produced from genetically 
modified organisms' [4]. In addition these recommendations should be applied for seed. Only 
detection procedures which are intended for an event-specific quantification (e.g. by real-time 
PCR approach) of material derived from a GMO are covered. 
 
 
1.2 Procedures for the estimation of measurement uncertainty 
 
MU is generally thought of as applying to quantitative measurements. Thus, in the GMO 
sector it will apply to the quantitative estimation of the 'concentration' (however expressed) of 
an authorised GMO. The concept will also apply qualitatively in the case of both authorised 
and non-authorised GMOs (i.e. confirmation of presence/absence). This latter aspect is 
increasingly being recognised as being of importance, but work on 'Qualitative Measurement 
Uncertainty' is only just commencing at the international level [5]. 
  
MU, which should take account of all effects on a measurement process, is the most important 
single parameter that describes the quality of measurement. The MU is linked to the 
individual measurement performed but not to a real-time PCR method as such. Therefore each 
laboratory has to evaluate the specific MU for a measurement results obtained under defined 
conditions. The uncertainty arises both from sampling and analysis, unless it could be proven 
that the sampling carried out is representative and that sampling uncertainty can therefore be 
neglected. It should be noted that generally a large amount of MU can arise from the upstream 
sampling stage, this is however not the rationale of this document and this guidance document 
addresses only the MU arising downstream the sampling stage. 
Significant progress has been made in devising procedures to estimate the uncertainty that 
originates in the analytical portion of the measurement, and guidance on these procedures is 
available. It has, however, become increasingly apparent that sampling is often an important 
contribution to uncertainty and requires equally careful management and control. Thus, the 
uncertainty arising from the sampling process should be evaluated. While existing guidance 
identifies sampling as a possible contribution to the uncertainty in a result, procedures for 
estimating the resulting uncertainty are not well developed and further, specific, guidance is 
required. At this time this guidance document will only consider analytical MU, but will be 
revised as further information, most notably that from the EURACHEM Working Group 
                                                 
[2] Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official 
controls performed to ensure the verification of compliance with feed and food law, animal health and animal 
welfare rules, Official Journal of the European Union, L 165 
[3] Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on 
genetically modified food and feed, Official Journal of the European Union, L 268/1 
[4] Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 
concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed 
products produced from genetically modified organisms and amending Directive 2001/18/EC, Official Journal of 
the European Union, L 268/24 
[5] IUPAC Project 2005-024-2-600 (Guidelines for validation (interlaboratory) of qualitative methods)  
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dealing with sampling uncertainty, becomes available. The issue has also been discussed in 
the Codex Committee on Methods of Analysis and Sampling [6]. 
It is important to recognise that there is always a MU associated with an analytical result 
reported by a control laboratory, whether or not the MU is reported. It should be noted that 
control laboratories testing for compliance with regulations (EC) No 1829/2003 and 
1830/2003 must report MU uncertainty together with the measurement result. 
 
The first recognised approach to MU, the 'Guide to Expression of Uncertainty in 
Measurement' (GUM) [7] lays down general rules for the expression and estimation of MU. 
GUM introduces the idea of uncertainty and distinguishes it from errors. It furthermore 
describes the steps involved in the estimation of uncertainty. GUM places emphasis on the 
component-by-component approach, in which the method is dissected and incremental 
calculations of uncertainty are made and eventually added up to provide a combined 
uncertainty. 
The evaluation of the measurement uncertainty for a method requires the analyst to look 
closely at all the possible sources of uncertainty in the method concerned; this approach is 
called 'bottom-up approach'. As a visualisation tool cause and effect diagrams also named 
'fishbone diagrams' are used and practical studies are carried out to help identifying the major 
source of uncertainty associated with the measurement. Figure 1 is giving examples of 
possible sources of MU for DNA quantification by real-time PCR. By concentrating on the 
major sources of uncertainty a good estimate of the uncertainty as a whole can be achieved, 
for further details the reader is referred to other documents exploiting this approach [8]. 
Once the measurement uncertainty has been estimated for a certain method in a particular 
laboratory, this estimate can be applied to subsequent results, provided that they are carried 
out in the same laboratory under the same conditions and that quality control data justify the 
correctness of this approach. In practice collaborative trail data are used to verify that the 
'bottom-up approach' chosen covers sufficiently all potential variations, if this is not the case 
major sources of uncertainty were incorrectly identified. 
 
                                                 
[6] CCMAS (April 2006): Uncertainty of Sampling, CX/MAS 06/27/10  
[7] ISO (1995): Guide to Expression of Uncertainty in Measurement, ISBN-9267-101889 
[8] EURACHEM / CITAC (2000): Quantifying Uncertainty in Analytical Measurement, second edition, 
EURACHEM Secretariat, BAM, Berlin (http://www.eurachem.ul.pt) 
 
 8
Calibration
PCR 
measurement 
result
DNA 
extraction
PCR 
conditionsDNA quality 
and purity 
Equal  
DNA 
extraction 
of targeted 
sequences
Sample 
homogeneity
PCR 
inhibition
Dilution
Repeatability
Particle 
size
PCR 
instrument
Type of 
calibrant, 
commutability
Storage 
of 
extracts
Storage of 
calibrants
DNA 
quantity 
PCR 
inhibition
Data analysis
PCR 
instrument
PCR 
conditions
GM 
concentration 
 
 
Figure 1: Cause and effect diagram ('fishbone diagram') visualising examples for possible MU 
contributions for DNA quantification by real-time PCR. Contributions to the reproducibility are shaded 
grey.  
 
It is desirable that information available as a result of accreditation requirements is used by 
the laboratories when estimating MU in order to avoid duplicate work being carried out. 
Additionally there has been some criticism of the practicability of the 'bottom-up approach' 
for the estimation of MU and two alternative ways are presented in this document. 
In the GMO food and feed sectors, where there is a high emphasis being placed on the use of 
methods of analysis validated through collaborative trials, information obtained from such 
trials can be used in many situations to estimate MU. However, it is important to note that 
data from collaborative trials can only be used if the findings are confirmed by internal quality 
control procedures.  
 
It is recommended that GMO laboratories use information derived from the following 
procedures to aid their estimation of the uncertainty of measurement results: 
• The ISO Guide to expression of uncertainty in measurement [7] 
• The EURACHEM Guide to quantifying uncertainty in analytical measurement [8]:  
  A. component-by-component approach 
  B. use of collaborative trial and/or internal quality control data 
These documents recommend procedures based on a component-by-component approach, 
method validation data, internal quality control data and proficiency test data. 
In many cases the overall uncertainty may be evaluated by an inter-laboratory (collaborative) 
trial by a number of laboratories and a number of matrices: 
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• IUPAC/ISO/AOAC International protocol for the design, conduct and interpretation of 
method performance studies [9] 
• ISO 21748 guidance document for the use of repeatability, reproducibility and trueness 
estimates in measurement uncertainty estimation [10] 
• ISO/IEC 17025 outlining the internal quality control approach [11] 
• Nordic Committee on Food Analysis (NMKL) suggesting the use of experimental data 
generated within the individual laboratory [12] 
• Nordtest report outlining the use of data obtained on routine samples for the estimation of 
MU [13]  
 
The above, and others, notably: 
• The concept set by Commission Decision 2002/657/EC implementing Council Directive 
96/23/EC concerning the performance of analytical methods and the interpretation of 
results [14] 
• An AOAC international approach [15] is outlined in the DG SANCO MU report [1]. 
 
It is recognised that further procedures for the estimation of MU may exist and are being 
developed, and that, in this evolving situation, further recommendations will be made as to 
acceptable procedures. As an example, it is anticipated that procedures based on results 
obtained from participation in proficiency testing schemes will be developed. 
 
 
                                                 
[9] Horwitz W (1995): Protocol for the Design, Conduct and Interpretation of Method Performance Studies, Pure  
Appl. Chem., 67, 331-343 
[10] ISO/TS 21748 (2004): Guidance for the use of repeatability, reproducibility and trueness estimates in 
measurement uncertainty estimation    
[11] ISO/IEC 17025 (2005): General requirements for the competence of testing and calibration laboratories   
[12] NMKL (1997): Estimation and expression of measurement analysis in chemical analysis, procedure No5  
[13] Magnusson B, Näykki T., Hovind H, Krysell M (2004): Handbook for Calculation of Measurement 
Uncertainty in Environmental Laboratories, TR 537 of 2004-02 
[14] Commission Decision  2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC 
concerning the performance of analytical methods and the interpretation of results, Official Journal of the 
European Union L221 (Text with EEA relevance) (notified under document number C (2002) 3044)  
[15] Horwitz W (2003): The Certainty of Uncertainty Journal of AOAC INTERNATIONAL, 86, 109-111  
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1.3 State of the art of collaborative trials in GM quantification 
 
Currently, more than 23 collaboratively tested quantitative real-time PCR-based methods, 
with at least 6 participants per trial, have been published. The majority of collaboratively 
tested methods were conducted with sample and calibration material such as ground seed as it 
is available from IRMM. Material from the same source was used as unknown sample and as 
material for the establishment of the calibration curve. Hence, any matrix effect which might 
have an influence on the MU will not be identified by this approach. Some trials were 
conducted using DNA that was simply provided by the organising institute and do not cover 
the DNA extraction step. Several trials use a common source of primer, probes and 
polymerase, which leads as well to a lower value for the reproducibility. In case only one type 
of PCR instrument is used the reproducibility investigated is only valid for this type of 
instrument. Additionally it should be noted that collaborative trials are never carried out under 
routine conditions.  
 
The potential bias associated with results may not reflect real measurements, where the 
calibration matrix may not exactly match the analytical sample matrix. In order to estimate the 
size of such effects a reconciliation procedure can be used. For an example see Annex II.  
 
In general, a list of collaborative trials including results can be found in ISO standard 21570 
[16]. Additionally method validations carried out by the Community Reference Laboratory 
(CRL) for GMO food and feed can be found on the CRL homepage [17]. Codex Alimentarius 
Commission is currently developing a document called 'Consideration of the methods for the 
detection and identification of foods derived from biotechnology', which will list as well 
methods validated through collaborative trial. 
 
                                                 
[16] ISO 21570 (2005): Foodstuffs – Methods of analysis for the detection of genetically modified organisms 
and derived products – Quantitative nucleic acid based methods 
[17] Homepage of the Community Reference Laboratory for GMO food and feed: http://gmo-crl.jrc.it 
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2 The relationship between the analytical result and 
measurement uncertainty, with particular reference to 
regulation (EC) No 1829/2003 and (EC) No 1830/2003 
 
 
2.1 General description of the estimation and use of measurement uncertainty 
 
The general process of estimating and using MU entails: 
 
− the evaluation of all possible sources of uncertainty in the method concerned and 
identification and combination of the major sources of uncertainty ('bottom-up approach'); 
or alternatively 
− the use of collaborative trial and/or single-laboratory validation data and/or in-house 
quality control data to estimate relation between sample concentration (c) and standard 
uncertainty (u); and 
− the calculation of the Critical Level (LC), Limit of Detection (LOD) and Limit of 
Quantification (LOQ) from u 
 
The estimation of MU is achieved by the estimation of two values u0, the standard uncertainty 
associated with results of the measurement of low concentrations of GM, and RSU the relative 
standard uncertainty associated with the results of the measurement of high concentrations of 
GM (Section 2.4). The value for u0 can be estimated by extrapolation, provided that 
measurement results for samples close to the LOQ are available. In the other case the analysis 
of diluted samples should be considered. RSU can be estimated using collaborative trial data, 
in-house quality assurance data or single laboratory validation data. Examples based on 
collaborative trial and in-house quality assurance data are given below.  
 
The estimates of the standard uncertainty can be based on collaborative trial data, provided 
the laboratory can confirm, via internal quality control (IQC) data, that it is able to achieve the 
same performance of the laboratories that took part in the trial. If the estimate of the standard 
uncertainty derived from collaborative trial does not cover the complete reproducibility due to 
the set-up of the trial, a reconciliation procedure should be used to estimate the contribution of 
effects not investigated in the trial (Annex II). Each significant source of uncertainty not 
covered by the collaborative trial data should be evaluated in the form of a standard 
uncertainty and combined with the reproducibility standard deviation [8]. During the 
'reconciliation' stage, it is necessary to identify any sources of uncertainty that are not covered 
by the collaborative trial data. The sources which may need particular consideration are [8]: 
 
• Sampling: Collaborative trials rarely include a sampling step.  If the method used in-
house involves sub-sampling, or the measurand is estimating a bulk property from a small 
sample, then the effects of sampling should be investigated and their effects included. 
• Pre-treatment: In most trials, samples are homogenised, and may additionally be 
stabilised, before distribution. It may be necessary to investigate and add the effects of the 
particular pre-treatment procedures applied in-house. 
• Method bias: Method bias is often examined prior to or during interlaboratory study, 
where possible by comparison with reference methods or reference materials. Where the bias 
itself, the uncertainty in the reference values used, and the precision associated with the bias 
check, are all small compared to the repeatability standard deviation (sR), no additional 
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allowance need be made for bias uncertainty. Otherwise, it will be necessary to make 
additional allowances. 
• Variation in conditions: Laboratories participating in a trial may tend towards the 
means of allowed ranges of experimental conditions, resulting in an underestimate of the 
range of results possible within the method definition. Where such effects have been 
investigated and shown to be insignificant across their full permitted range, however, no 
further allowance is required. 
• Changes in sample matrix: The uncertainty arising from matrix compositions or levels 
of interferents outside the range covered by the trial will need to be considered. 
 
In cases were no collaborative trial data are available, the MU can be estimated from 
analytical results measured within the laboratory concerned. Preference should, however, be 
given to data obtained through collaborative trials. 
 
 
2.2 Calculation of measurement uncertainty from collaborative trial data and 
confirmed by internal quality control data 
 
A collaborative trial is usually carried out once as a part of method validation, or at relatively 
infrequent intervals during the working lifetime of a method; it tells the analyst what 
performance they can expect for the method applied. However, attention needs to be paid that 
the MU estimated from a method validation carried out by collaborative trial covers all 
measurement steps contributing to the MU (Figure 2). 
 
In order to use MU estimates from collaborative trials properly, it is important that the same 
replication (e.g. two PCRs of one DNA extract), more or less the same Ct values and design 
of the calibration curve are used to produce a single measurement result in the laboratory. 
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Figure 2: Contributions to the estimation of the MU within one laboratory 
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In general, sR determined in a collaborative trial can be used as an estimate of MU if the 
following conditions are met: 
 
• the collaborative trial studied the whole method using sample types similar to those 
being measured in the laboratory; 
• repeatability in the laboratory is similar to the repeatability reported in the 
collaborative trial; 
• within-laboratory reproducibility is not larger than the reproducibility reported in the 
trial; 
• results from the analysis of Certified Reference Materials (CRMs) in the laboratory do 
not display significant bias, provided the relevant CRM properties correspond fully to 
those of the test sample; 
• a true value has been assigned to the test material independently of the test results. 
 
If these conditions are not met then estimates of the additional uncertainty components must 
be combined with the collaborative trial sR to provide an estimate of MU. 
 
Within this sector, collaborative trials are often undertaken using samples containing a range 
of concentrations of GM material, including the concentrations close to LOQ. The 
uncertainties u0 and RSU can be estimated by plotting sR of collaborative trials against the 
assigned value (or mean) of the concentration of GM and calculating the linear regression. 
The intercept of a linear regression (or sR associated with the lowest concentration) can be 
used as an estimate of u0 and the slope of the linear regression can be used as an estimate of 
RSU. If the intercept is negative or the lowest concentration is close to the LOQ, sR associated 
with the lowest concentration can be used as an estimate of u0. 
 
CRMs are well suited for the estimation of bias and its control in IQC. Measurement variation 
is best estimated and controlled by the repeated independent analysis of samples. If a CRM is 
employed as an 'unknown sample' for IQC, material from a different source should be used 
for calibration. 
 
 
2.3 Calculation of measurement uncertainty from internal quality control data 
 
MU can be estimated using the value of within-laboratory reproducibility; provided it could 
be proven that no bias exists. The general approach is to estimate the value of within-
laboratory reproducibility (measurement variation) using the repeated independent analyses of 
a range of real samples, and to carry out a bias control using CRMs. The use of normal quality 
assurance procedures and measurements results obtained on routine samples should mean that 
suitable data are readily available [12, 13]. For new methods, where quality assurance data is 
not available, suitable analytical results can be obtained from a within-laboratory method 
validation [13]. The approach is presented in Section 2.3.1. 
 
In order to ensure that the analytical result and its uncertainty cover the true concentration of 
GM in a sample, it is important to prove that no bias exists. 
An example for the calculation of MU based on internal quality control data is given in Annex 
III. 
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2.3.1 Within-laboratory reproducibility 
 
The within-laboratory reproducibility can be estimated using measurements results obtained 
on routine samples as outlined in the NMKL procedure No. 5 [12] or the Nordtest report [13]. 
The following approach is based on the Nordtest report [13], a calculation example can be 
found in Annex III. 
 
It is important that the estimation of MU covers all steps of the analytical procedure. Hence, 
within-laboratory reproducibility should be determined by the repeated independent analyses 
of samples in analytical runs that represent the long-term variation of analytical components 
within the laboratory, e.g. different operators, stock solutions, new batches of critical 
reagents, recalibrations of equipment. Also, samples should represent the different matrices 
and concentrations to which the estimates of MU will be applied. In particular, samples with a 
GMO content close to legal or contractual thresholds against which results will be compared 
should be included (e.g. 0.9 % for approved events in unlabelled food products). 
 
Uncertainty estimates should be updated by the addition of new results as they become 
available. Once a database is established then it may be advisable to remove results that are 
older than one year, from the estimation of measurement uncertainty, if new results are 
generated frequently. In regular intervals revalidation should be considered. 
 
Repeated independent results produced by at least 15 samples should be used. Usually there is 
a limited resource that can be devoted to measurements that are used to estimate uncertainty. 
Therefore, in order to maximise the matrices and concentrations studied it is recommended 
that the smallest replication (i.e. two independent measurements (n = 2) per sample,) are 
applied to the largest number of samples possible. In the context of the Nordtest [13] 
'duplicate measurements' mean two independent examples of the measurement as it is usually 
applied in the laboratory. For example, if it is the usual practice to report results as the mean 
of two analyses then the two independent measurements will consist of two results each given 
by the mean of two analyses. 
 
The mean ( ic ) of two independent analytical results is calculated as: 
 
2
2,1, ii
i
ccc +=     Equation 1 
ic .........mean of two analytical result 
1,ic ....... result of first analysis of sample i 
2,ic ...... result of second analysis of sample i 
 
The absolute difference ( id ) between the first and the second analysis is calculated as: 
 
2,1, iii ccd −=     Equation 2 
 
id ........absolute difference between two analytical result 
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1,ic ....... result of first analysis of sample i 
2,ic ...... result of second analysis of sample i 
 
The relative difference between analyses (radi) is calculated as: 
 
100
i
ii c
drad =     Equation 3 
radi ........... relative difference  
id ........absolute difference between two analytical result 
ic .........mean of two analytical result 
 
Given a set of differences and relative differences calculated from the analysis of a number of 
samples the average difference ( d ) and average relative differences ( rad ) can be calculated. 
 
The within-laboratory sR is in the case of two independent measurements results (n = 2) given 
by: 
 
13.12
d
d
ds ==R     Equation 4 
sR ..........within-laboratory reproducibility standard deviation 
d2 ..........constant depending on the number or independent measurements (n) [13]: 
 
Table 1: Factor d2 depending on the number of independent measurement results carried out on one 
sample 
n d2 
2 1.128 
3 1.693 
4 2.059 
5 2.326 
6 2.534 
7 2.704 
8 2.847 
9 2.970 
10 3.078 
 
Note: In case more than two independent measurement results are measured, di reflects the 
range between the lowest and the highest results measured. 
  
The within-laboratory reproducibility relative standard deviation (RSDR) is given by 
 
13.1
radRSDR =      Equation 5 
RSDR .... relative within-laboratory reproducibility 
rad ....... average relative differences 
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2.3.2 Method and laboratory bias control 
 
After the measurement of a CRM the absolute difference between the mean measured value 
and the certified value can be calculated as: 
CRMmm cc −=∆     Equation 6 
∆m ..............absolute difference between mean measured value and certified value 
cm ...............mean measured value 
cCRM .........certified value 
 
The uncertainty of ∆m is u∆, that is calculated from the uncertainty of the certified value and 
the uncertainty of the measurement result according to: 
22
CRMm uuu +=∆     Equation 7 
u∆ ..........combined uncertainty of result and certified value (= uncertainty of ∆m) 
um..........uncertainty of the measurement result 
uCRM......uncertainty of the certified value 
 
 
The uncertainty of the measurement result (um) can be estimated with the help of the relative 
standard deviation of the repeatability (sr) and d2 (Section 2.3.1). Alternatively the uncertainty 
of the measurement results (um) can be estimated by dividing the standard deviation by the 
square root of the number of measurements carried out: 
n
su rm =      Equation 8 
um..........uncertainty of the measurement result 
sr ........... standard deviation of the repeatability 
n ...........number of independent measurement results  
 
The expanded uncertainty U∆, corresponding to a confidence level of approximately 95 %, is 
obtained by multiplication of u∆ by a coverage factor k = 2. 
 
∆∆ = uU *2      Equation 9 
U∆ .............. expanded uncertainty of difference between result and certified value 
u∆ ............... combined uncertainty of result and certified value 
 
If ∆m  ≤ U∆ then there is no significant difference between the measurement result and the 
certified value, meaning that the method does not have a bias. In case a bias was found the 
cause has to be investigated and eliminated. Approaches to calculate a bias can be found in 
GUM [2], but have to be considered carefully as a bias may be a constant or a factor. 
The expanded uncertainties UCRM of each certified value are given on the certificate of each 
individual reference material. The standard uncertainty, uCRM, of the certified value is 
obtained by dividing the stated expanded uncertainty by the coverage factor given on the 
certificate.  
Note: The Nordtest report [13] mentions a factor of 2.8 which should not be mixed-up with 
the coverage factor k = 2, leading to a confidence of about 95 %. Factor 2.8 can be used to 
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check if the MU estimated before is also applicable for measurements on a new sample. In 
case of inhomogeneity of the sample or the method being out of control, the before calculated 
MU might not be applicable any more. If the absolute difference between the two 
measurements is higher than 2.8 times the standard deviation, the MU calculation has to be 
reconsidered and /or the sample homogeneity questioned. 
Furthermore, it should be noted that the CRM used for the bias control should not at the same 
time be used for calibration. In case this can not be avoided the analysis of a CRM with a low 
GM concentration calibrated with the diluted extracts of a CRM with a higher GM 
concentration should be considered. 
 
2.3.3 Estimation of the uncertainty component associated with bias 
 
Uncertainty associated with bias should, where possible, be estimated by the measurement of 
CRMs. The general approach is to measure the concentration of GM in a CRM in a number of 
analytical runs. An estimate of the uncertainty associated with bias is gained by combining the 
uncertainty associated with the mean measurement result with the uncertainty associated with 
the certified value of the concentration of GM in the CRM. 
Note: In case of a bias the experimental set-up needs to be changed until no bias is found. 
 
The relative standard uncertainty associated with the bias (ubiasr) is given by: 
22
100⎟⎟⎠
⎞
⎜⎜⎝
⎛+=
CRM
CRMRbiasr c
u
n
RSDu   Equation 10 
RSDR..... relative within-laboratory reproducibility 
n ...........number of measurements 
uCRM ..... standard uncertainty associated with the certified value of the CRM 
cCRM .....certified value of the CRM 
 
Note: UCRM of each certified value is given on the certificate of each individual reference 
material. The standard uncertainty, uCRM, of the certified value is obtained by dividing the 
stated expanded uncertainty by the coverage factor given on the certificate. 
2.3.4 Calculation of the relative standard uncertainty 
 
The relative standard uncertainty (RSU) is calculated by combining relative variation (RSDR ) 
and relative uncertainty associated with bias (ubiasr) using: 
 
22
biasrR uRSDRSU +=    Equation 11 
RSDR .............within-laboratory reproducibility 
ubiasr ...............standard uncertainty associated with biasr 
 
Note: The individual standard uncertainties need to have the format of a standard deviation in 
order to allow summing up. Independent uncertainties can be combined by taking the square 
root of the sum of the individual squares. RSU and ubiasr are not completely independent from 
each as all measurements are influenced by the RSDR (Equation 10 and 11). The effect is 
considered to be negligible. Additionally it should be noted that in some cases either RSU, or 
u0 can be zero. 
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The laboratory should generally explain how the MU has been calculated. Additionally the 
coverage factor applied and the corresponding uncertainty levels should be stated. A general 
explanatory note can be prepared to ease communication.  
 
 
2.4 Evaluation of measurement uncertainty 
 
Given of absolute standard uncertainty (u0) and relative standard uncertainty (RSU) estimated 
from collaborative trial results (Section 2.2) or in-house quality control data (Section 2.3) then 
the standard uncertainty u associated with a measurement result c is given by: 
 
( )220 RSUcuu ×+=    Equation 12 
uo ...................absolute standard uncertainty 
c.....................measurement result 
RSU ...............relative standard uncertainty 
 
Note: It has to be stressed that Equation 12 is valid under the assumption that u0 is constant 
and RSU proportional to the concentration c. This assumption should be checked using in-
house validation data. A situation can occur, that u0 is so small that it can be neglected (see 
example in Annex III). 
 
Regulations (EC) No 1829/2003 and (EC) No 1930/2003 set a labelling threshold for the total 
authorised GMO presence on an ingredient basis. As such, the GMO contents for various 
events of one ingredient (e.g. MON 810 maize and 1507 maize) must be added together and 
the uncertainties associated with each individual GMO measurement combined. The MU of 
various methods can be combined by adding the squares and taking the square root of the 
sum: 
 
∑ == ni imethc uu ,1 2 ,     Equation 13 
uc ...................combined standard uncertainty associated with the measurement result for one ingredient 
n ....................number of method applied 
umeth,i ..............absolute standard uncertainty of individual method  
 
 
The expanded uncertainty U (giving a confidence level of approximately 95 %) is given by: 
 
cuU ×= 2      Equation 14 
uc ...................combined standard uncertainty associated with the measurement result for one ingredient 
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2.5 Calculation of the critical level 
 
The critical level (LC) is the lowest measurement result that demonstrates with sufficient 
confidence that the analyte is present (Figure 3). LC is given by 
 
02 u×=LC    `  Equation 15 
uo ...................absolute standard uncertainty 
 
 
0 LC
k×u0 α
 
Figure 3: The LC is the lowest measurement result that demonstrates with sufficient confidence that the 
analyte is present (concentration > 0).  If a value of k = 2 is used to estimate LC then the probability (α) of 
a sample containing none of the analyte giving a result above LC is 2.5 %. 
 
 
2.6 Calculation of the limit of detection and quantification 
 
Figure 4 illustrates the connection between LC and LOD. The LC is a statistically calculated 
number. If the result of the measurement is less than LC, then we can explain (with 95 % 
confidence) that the current sample does not contain any analyte. We use a t-statistic to decide 
if the expected value of GM concentration is 0 or not. If our measurement result is smaller 
than LC then we can report with 95 % confidence, that the sample does not contain any GM. 
If the measurement result is above LC, we are sure that GM is present. It should be noted that 
the probability to take a result for a blank is 50 % for measurement results below the LC. 
While LC refers to the measurement result, the LOD and LOQ refer to the measured GMO 
concentration. Above the LOD, the probability to wrongly take a blank for a result is the same 
as for the LC while the probability to incorrectly interpret a signal for the presence of a GM is 
5 %. It will be sure to detect a GM if the measurement result is above the LOD. The LOQ is 
the measured GM concentration at which the measurement uncertainty is below a certain 
(arbitrarily chosen; usually 30 %) value. 
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0 LC LOD
β
 
Figure 4: The LOD is the lowest true concentration that we can be sufficiently confident of detecting.  This 
means it is the lowest true concentration that is unlikely to give a result below the critical level.  If it is 
estimated as the lowest concentration where the lower limit of the expanded (k = 2) uncertainty is greater 
then the LC then the probability (β) of not detecting the analyte present at a concentration equal to the 
LOD is 2.5 % 
 
 
The LOD is given by: 
 
2
0
41
4
RSU
uLOD −=     Equation 16 
uo ...................absolute standard uncertainty 
RSU ...............relative standard uncertainty 
 
 
The LOQ is given by: 
 
22
2
0
RSURSU
uLOQ
MAX −
=    Equation 17  
uo ...................absolute standard uncertainty 
RSU ...............relative standard uncertainty 
RSUMAX .........largest acceptable relative standard uncertainty  
 
Note: Where the value of LOQ calculated using Equation 17 is less than the value of LOD 
then LOQ = LOD. 
For the calculation of uo the user needs to investigate whether the lowest concentration 
analysed is close to the LOQ of the method (Section 2.2). 
  
Where RSUMAX is the largest acceptable relative standard uncertainty that can be associated 
with results. By collaborative trial we can consider it as the greatest acceptable gradient of the 
regression line. 
 
Note: LOD and LOQ are frequently estimated as multiples of u0 with the LOD equal to 4-
times u0 and the LOQ 9-times u0. This approach would require a constant u0, as this is not 
given for values measured below the LOQ, the approach given here was favoured. However, 
estimating LOD and LOQ as multiples of u0 could be still used, when the necessary 
precautions are taken. 
 22
2.7 Reporting results 
 
Measurement results should be reported as follows: 
 
Where c > LOQ 
 
' U)cionConcentrat ±= (  
The uncertainty reported with this result is an expanded uncertainty calculated from a 
standard uncertainty using a coverage factor of 2.  It is equivalent to a confidence level of 
approximately 95 %.' 
 
Where LC < c < LOQ 
 
Report ' U)cionConcentrat ±= ( 'unless it is not possible to estimate concentrations below 
LOQ (e.g. where LOQ is also the lowest point on the calibration curve). 
If this is the case report the result as ' )( LOQULOQ +≤ ionConcentrat ' where ULOQ is the 
expanded uncertainty at a concentration equal to the LOQ. 
 
 
Where c < LC 
 
' LC<ionConcentrat  
The target GM has not been detected in this sample.' 
 
 
2.8 Estimation of the uncertainty associated with the mean 
 
Where the RSU associated with an individual measurement result is estimated from the results 
of a collaborative trial ( RRSDRSU = ) then the RSU associated with the mean of n 
independent replicates is given by: 
 
 
( )
n
nRSDRSDRSU repRn 1
2
2 −−=  Equation 18 
RSUn..............RSU associated with the mean result  
RSDR .............relative standard uncertainty  
RSDrep............relative standard deviation describing between-replicate variation  
n .................... number of independent measurements 
 
 
 
 
Where nRSU  is the relative standard uncertainty associated with the mean result and repRSD  
is the relative standard deviation describing between-replicate variation.  The value of RSDrep 
can be estimated using the method described in Section 2.3.1. 
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2.9 How to use measurement uncertainty 
 
The MU report of DG SANCO [1] states that Enforcement Authorities shall use the 
measurement uncertainty associated with an analytical result when deciding whether an 
analytical result falls within the specification for food and feed control purposes. The way that 
MU is to be used by Enforcement Authorities must be taken into account when analytical 
specifications are discussed. In practice, the analyst will determine the analytical result and 
estimate the MU at that level. The value obtained by subtracting the uncertainty from the 
reported concentration, is used to assess compliance. Only if that value is greater than the 
maximum concentration stipulated in legislation, it is sure 'beyond reasonable doubt' that the 
sample concentration of the analyte is greater than that prescribed by legislation. 
 
The estimated MU must be reported together with the measurement result. The uncertainty is 
of special importance, when the range of the expanded uncertainty encompasses the legal 
limit [11]. 
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3 Further considerations 
 
The authors consider that the two approaches given are efficient ones. However, other 
approaches to estimate the MU may be used. Furthermore, the authors wish to communicate 
further considerations which should be made when estimating the uncertainty linked to GMO 
quantification measurements by real-time PCR. In general these issues are currently 
recognised and discussed and their implications are evaluated at present. 
 
Regulation (EC) No 1829/2003 and (EC) No 1930/2003 set a labelling threshold for the total 
authorised GMO presence on an ingredient basis. The MU and LODs associated with a 
sample are influenced by the level to which the ingredient itself is present. In compound food 
and feed the ingredient under investigation resembles less than 100 %. Although the GMO 
concentration of interest from a legislative perspective is the same, the number of DNA 
targets can be much lower in compound stuff, which can lead to quantifications close to the 
LOD. 
Recent years have witnessed major advances with respect to technology and methods used to 
identify ingredients derived from GM materials, such as real-time PCR platforms and 
microarrays. However, this rapid advance in technological expertise has not been mirrored by 
a concurrent progression in the bio-analytical measurement community. Until now data 
handling of data obtained during GM detection has not be standardised [18]. 
 
The estimation of MU in any analytical approach attempts to identify all components that add 
significant variability to the end result. As such, MU estimation must take into account the 
whole analytical process from the initial generation of the result through to its final reporting. 
Whilst most MU estimation is focused on the practical experiments associated with the 
analytical process, little work has been done to explore the analysis of the data associated with 
such experiments. Example approaches to data handling that can contribute to MU are shown 
in Annex IV. 
 
Statistical consideration of the amplification process used in quantitative PCR determinations 
suggests that the variation displayed by measurement results are described by a mixture of 
normal, binomial, and lognormal distributions, dominated by the latter two. A recent trial [19] 
has shown that GMO proficiency test results consistently follow a positively skewed 
distribution. Log-transformation prior to calculating z-scores is effective in establishing near-
symmetric distributions that are sufficiently close to normal to justify interpretation on the 
basis of the normal distribution. It is therefore recommended that data from real-time PCR 
analyses should be log-transformed before calculation of the MU.  
 
The estimation of the uncertainty associated with qualitative analysis of unauthorised GMOs 
is more difficult to determine than that associated with quantitative analysis of authorised 
GMOs because of the lack of validated methods, calibrants and CRMs.  Generally acceptable 
                                                 
[18] Burns M, Valdivia H, Harris N (2004): Analysis and interpretation of data from real-time PCR trace 
detection methods using quantitation of GM soya as a model system, Analytical and Bioanalytical Chemistry, 
378(6), 1616-1623 
[19] Thompson M, Ellison SLR, Owen L, Mathieson K, Powell J,  Key P, Wood R, Damant A (2006): Scoring 
in Genetically Modified Organisms Proficiency Tests Based on Log-Transformed Results, JAOAC, 89(1), 232-
239 
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guidance on this topic is still under development. However, suggested guidance and an 
example of the estimation of LC and LOD for qualitative analysis is given in Annex IV. 
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ANNEX I: Definitions applicable to GMO analysis 
 
Measurement Uncertainty (MU) 
Parameter, associated with the result of a measurement, that characterises the dispersion of the 
values that could reasonably be attributed to the measurand [20]. 
 
Notes: 
1. The parameter may be, for example, a standard deviation (or a given multiple of it), or the 
half-width of an interval having a stated level of confidence. 
2. Uncertainty of measurement comprises, in general, many components. Some of these 
components may be evaluated from the statistical distribution of results of a series of 
measurements and can be characterised by experimental standard deviations. The other 
components, which can also be characterised by standard deviations, are evaluated from 
assumed probability distributions based on experience or other information. 
3. It is understood that the result of a measurement is the best estimate of the value of a 
measurand, and that all components of uncertainty, including those arising from systematic 
effects, such as components associated with corrections and reference standards, contribute to 
the dispersion. 
 
Accuracy 
The closeness of agreement between a test result and the accepted reference value (adopted 
from [21]).  
 
Applicability 
The description of analytes, matrices, and concentrations to which a method can be applied. 
(modified from [22]).  
 
Bias  
Difference between mean measured value from a large series of test results and an accepted 
reference value (a certified or nominal value). The measure of trueness is normally expressed 
in term of bias [12]. 
 
Critical level (LC) 
The lowest measurement result that demonstrates with confidence that the analyte is present 
[modified from 23]. 
 
Dynamic range - Range of quantification 
The range of concentrations over which the method performs in a linear manner with an 
acceptable level of accuracy and precision. 
 
Expanded measurement uncertainty 
The expanded uncertainty (U) allows to calculate an interval within which the value if the 
measurand is believed to lie with a higher level of confidence. U is obtained by multiplying 
the combined standard uncertainties by a coverage factor k. The choice of the factor k is based 
                                                 
[20] ISO (1993): International vocabulary of basic and general terms in metrology, second Edition 
[21] ISO/FDIS 3534-1 (2006): Statistics - Vocabulary and symbols - Part 1: General statistical terms and terms 
used in probability 
[22] Codex CX/MAS 02/4 (2002): Proposed draft guidelines for evaluating acceptable methods of analysis 
[23] IUPAC recommendation (1995): Nomenclature in evaluation of analytical methods including detection and 
quantification capabilities, Pure & Appl. Chem., 67(10), 1699-1723  
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on the level of confidence desired. For an approximate level of confidence of 95 %, k is 
always 2 if the degree of freedom is > 2 [adopted from 8]. 
 
Limit of Detection (LOD)  
Limit of detection is the lowest concentration or content of the analytes that can be detected 
reliably, but not necessarily quantified (slightly modified from [24]). LOD is generally 
expressed as the amount of analyte at which the analytical method detects the presence of the 
analyte at least 95% of the time (< 5% false negative results).  
 
Limit of Quantification (LOQ)  
The limit of quantification of an analytical procedure is the lowest amount or concentration of 
analyte in a sample, which can be quantitatively determined with an acceptable level of 
precision and accuracy (modified from [24]).  
 
Practicability  
The ease of operations, in terms of sample throughput and costs, to achieve the required 
performance criteria and thereby meet the specified purpose (modified from [24]). Generally, 
the method should be practical for its intended purposes.  
 
Repeatability standard deviation (RSDr)  
The standard deviation of test results obtained under repeatability conditions.  Repeatability 
conditions are conditions where test results are obtained with the same method on identical 
test items in the same laboratory by the same operator using the same equipment within short 
intervals of time (adopted from [21]).  
 
Reproducibility standard deviation (RSDR)  
The standard deviation of test results obtained under reproducibility conditions.  
Reproducibility conditions are conditions where test results are obtained with the same 
method on identical test items in different laboratories with different operators using different 
equipment [21]. 
 
Recovery 
Proportion of the amount of analyte, present in or added to the analytical portion of the test 
material, which is extracted and presented for measurement. 
 
Robustness  
The robustness of an analytical method is a measure of its capacity to remain unaffected by 
small, but deliberate variations in method parameters and provides an indication of its 
reliability during normal usage (adopted from [25]).  
 
Sensitivity  
The sensitivity of a method is a measure of the magnitude of the response caused by a certain 
amount of analyte.  
The method should be sensitive enough in order to be able to detect/quantify with respect to 
the thresholds as provided in the relevant legislation.  
                                                 
[24] ISO/FDIS 24276 (2005): International Standard, Foodstuffs – Methods of analysis for the detection of 
genetically modified organisms and derived products – General requirements and definitions  
[25] EMEA (1995): Validation of analytical methods: definitions and methology, CPMP/ICH/381/95, 
http://www.emea.eu.int/pdfs/human/ich/038195en.pdf  
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Since sensitivity is method- and purpose-dependent it should be specified in the protocol.  A 
reasonable goal for sensitivity is that required to meet levels specified in contracts, with a 
reasonable certainty that the level does not exceed the required limit.   
Sensitivity as a term is used in two different ways - LOD and the slope of a curve.  The use of 
the LOD is the preferred term to use as a measure of the ability of a method to detect a small 
amount of analyte. 
 
Specificity 
Property of a method to respond exclusively to the characteristic or analyte of interest.  
 
Standard uncertainty 
Uncertainty of the result of measurement expressed as a standard deviation [7]. 
 
Trueness  
The closeness of agreement between the average value obtained from a large series of test 
results and an accepted reference value (adopted from [21]). 
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ANNEX II: Example for an international collaborative trial to 
determine accuracy of a real-time PCR procedure 
 
This Annex gives a detailed description of the concept and execution of an international 
collaborative trial in order to validate a real time PCR based method to quantify Roundup 
Ready® soya (RRS). 
 
The collaborative trial was carried out in the year 2000. In total 31 laboratories took part in 
the trial, either using the ABI Prism® 7700 SDS (14 participants), ABI Prism® 5700 SDS 
(5 participants) or the LightCycler® system (12 participants). 
 
In total five unknown samples containing between 0.1% and 5 % (m/m) of CRM IRMM-
410R [26] and one sample consisting of texturized vegetable protein (TVP) containing 2 % 
(m/m) of the soya bean line GTS 40-3-2 were used in this trial. 
 
The trial encompassed the whole procedure as needed for analysing a test sample, including 
the DNA extraction carried out according to a pre-scribed protocol using the classical CTAB 
solution and the PCR step. For each sample two DNA extractions have been analysed in 
parallel. Each test sample was analysed in 3 independent replicates. The mean value together 
with the standard deviation was reported. 
 
For the relative quantification, separate standard curves were established for the reference 
target sequence and for the GMO target sequence. Therefore, DNA from 5 % (m/m) CRM 
IRMM-410R was extracted and used as a calibrant for both standard curves. At each of the 
four calibration points, duplicate (ABI PRISM® 7700 SDS and GeneAmp®5700) or single 
determinations (LightCycler System) were performed using a series of 1:4 dilution intervals. 
Finally, the copy number measured for the unknown samples were obtained by interpolation 
from individual standard curves. Subsequently the percentages were calculated by dividing 
the copy number of the RRS copy number by the reference target sequence copy number and 
by multiplication with 100. 
 
For primer/probe systems and PCR conditions, respectively, see details in ISO 21570 [16]. 
 
Data on specificity, linearity, LOD and LOQ have been determined prior to the collaborative 
trial. 
 
Due to the concept of the trial, material from the same source was used as unknown samples 
(0.1, 0.5, 1, 2 and 5 % (m/m) CRM IRMM-410R) and as calibrant (5 % (m/m) CRM IRMM-
410R). Therefore the set-up of the study is not well suited for the evaluation of the trueness of 
the applied real-time PCR method. However, the results could be used for assessing the 
precision of the applied method, whereby the described issues reflect a worst-case scenario 
resulting in an underestimation of the precision of the applied real-time PCR method.  
 
                                                 
[26] Trapmann S, Le Guern L, Kramer GN, Schimmel H, Pauwels J, Anklam E, Van den Eede G, Brodmann P 
(2000): The Certification of a new set of Reference Materials of Soya Powder with different Mass Fractions of 
Roundup ReadyTM Soya, EC certification report EUR 19573 EN, ISBN 92-828-9639-0 
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As an example of the statistical evaluation of the results, Table 2 summarises the reported 
individual participant results using either the ABI Prism® 7700 SDS or ABI Prism® 5700 
SDS. For checking significant outliers a Cochran and Grubs test was applied to the results 
reported by the participants. Both independent results for each sample were averaged and 
tested. After elimination of identified outliers for the 0.5, 1 and 5 % samples the mean 
quantities and standard deviation were calculated. 
 
 
Table 2  Validation data for ABI PRISM ™ 7700 SDS and GeneAmp® 5700 SDS 
 
Sample Sample 1 
0.1 (m/m) %
Sample 2 
0.5 (m/m) %
Sample 3 
1  (m/m) % 
Sample 4 
2 (m/m) % 
Sample 5 
5 (m/m) % 
Sample 6 
2 (m/m) % TVP
Number of laboratories 19 19 19 19 19 19 
Number of outliers   0 2 1 0 1 0 
Number of laboratories retained 
after eliminating outliers 19 17 18 19 18 19 
Mean value [m/m %] 0.11 0.49 1.00 2.27 5.11 1.71 
Bias [%] 9 -1 0 13 2 -15 
Repeatability standard deviation 
sr 
0.04 0.12 0.21 0.25 0.53 0.48 
Repeatability relative standard 
deviation RSDr [m/m %] 
33 24 21 11 10 28 
Repeatability limit r 
(r = 2.8 x sr) 
0.10 0.33 0.59 0.71 1.48 1.34 
Reproducibility standard 
deviation sR 
0.05 0.3 0.28 0.71 1.38 0.55 
Reproducibility relative standard 
deviation RSDR [m/m %] 
44 27 28 32 27 32 
Reproducibility limit R 
(R = 2.8 x sR) 
0.13 0.37 0.77 2.00 3.87 1.54 
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Figure 5: Mean concentration (c) plotted against sR 
 
In this case, the lowest analysed concentration is presumably lower than the LOQ. The value 
of u0 is estimated from the value of sR associated with the lowest concentration sample: 
 
u0 = 0.05 
 
The value of RSU is estimated from the gradient of a linear regression line (with intercept set 
to zero) 
 
RSU = 0.29 
 
Hence the standard uncertainty associated with a measurement result c is given by (from 
Equation 14): 
 
( )22 290050 c..u ×+=  
 
Hence, LC is equal to a measurement result of (from Equation 15) 0.10 % (m/m) GM 
 
The LOD for the method is equal to a concentration of (from Equation 16) 0.30 % (m/m) GM. 
 
If a relative standard uncertainty of less than 30 % is required for fit for purpose quantitative 
results then the limit of quantification is given by (from Equation 17): 
 
LOQ = 0.6 % (m/m) 
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Given a measurement result 2.3 % (m/m) GM the expanded uncertainty is given by (from 
Equation 15): 
 
( )22 322900502 ...U ×+×= =1.3 % (m/m) 
 
Hence, the result should be reported as: 
 
'(2.3 ± 1.3) % (m/m) GM 
 
The uncertainty associated with the result is an expanded uncertainty calculated from a 
standard uncertainty using a coverage factor of 2. It is equivalent to a confidence level of 
approximately 95 %. The result minus the uncertainty is larger than 0.9 %.' 
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ANNEX III: Example for the evaluation of the measurement 
uncertainty based on single laboratory results 
 
Evaluation of within-laboratory reproducibility 
 
36 routine samples containing different concentration levels of RRS are analysed twice 
independently (Table 3) and are used to calculate the reproducibility standard deviation and 
relative standard deviation. 
 
Table 3: Measurement results obtained on routine samples (n = 2) and calculation of the relative 
difference 
 
Analysis 
number 
GM concentration 
ci,1  
 
[m/m %] 
GM concentration 
ci,2  
 
[m/m %] 
mean  
ic  
(Equation 1) 
difference 
di  
 
(Equation 2)  
relative difference 
radi [%] 
 
(Equation 3) 
 
32 0.104 0.101 0.102 0.003 2.9 
12 0.155 0.147 0.151 0.008 5.3 
30 0.142 0.170 0.156 0.028 17.9 
26 0.177 0.174 0.176 0.003 1.7 
29 0.220 0.320 0.270 0.100 37.0 
34 0.295 0.254 0.274 0.041 14.9 
17 0.328 0.262 0.295 0.066 22.4 
6 0.280 0.340 0.310 0.060 19.4 
35 0.303 0.331 0.317 0.028 8.8 
15 0.347 0.414 0.381 0.067 17.6 
22 0.360 0.485 0.423 0.125 29.6 
4 0.400 0.600 0.500 0.200 40.0 
16 0.691 0.614 0.652 0.077 11.8 
20 0.698 0.700 0.699 0.002 0.3 
10 0.641 0.823 0.732 0.182 24.8 
23 0.998 0.931 0.965 0.067 6.9 
8 1.352 1.349 1.351 0.003 0.2 
21 1.493 1.671 1.582 0.178 11.3 
14 1.948 1.250 1.599 0.698 43.7 
9 2.086 1.733 1.909 0.353 18.5 
18 2.017 1.879 1.948 0.138 7.1 
33 1.750 2.202 1.976 0.452 22.9 
13 2.331 2.466 2.398 0.135 5.6 
36 2.800 2.500 2.650 0.300 11.3 
1 4.300 3.900 4.100 0.400 9.8 
2 4.900 4.800 4.850 0.100 2.1 
28 5.600 5.700 5.650 0.100 1.8 
25 15.270 15.240 15.255 0.030 0.2 
11 23.224 20.197 21.710 3.027 13.9 
5 24.000 23.000 23.500 1.000 4.3 
3 36.000 41.000 38.500 5.000 13.0 
27 45.000 46.000 45.500 1.000 2.2 
19 53.985 56.187 55.086 2.202 4.0 
24 50.091 60.808 55.449 10.717 19.3 
7 71.000 82.000 76.500 11.000 14.4 
31 94.000 91.000 92.500 3.000 3.2 
 
 35
Here sR is estimated from the six results with the lowest mean concentration and RSDR is 
estimated from the remaining 30 results. 
 
Hence, 
 
03040.d =  
 
0269.0
13.1
0304.0 ==Rs  % GM 
 
rad = 13.1 % 
 
==
13.1
1.13
RRSD 11.5 % 
 
 
Method and Laboratory bias control 
 
For the bias control a CRM with a certified RRS concentration of (10.0 ± 1.6) g/kg was used 
(ERM-BF410d [27]). The certificate states that a coverage factor of k = 2 was applied. uCRM is 
therefore 0.8 g/kg. 
Six independent measurements (n = 6) were carried out (Table 4). 
 
Table 4: Measurement results obtained on a CRM 
 
Analysis 
number 
GM concentration 
c 
[g/kg] 
Mean GM 
concentration  
cm 
[g/kg] 
Standard 
deviation 
s 
[g/kg] 
1 11.0   
2 10.9   
3 12.1 11.1 0.5 
4 11.2   
5 10.7   
6 10.9   
 
The standard deviation (s) is divided by the square root of the number of measurements (n), as 
the average of the results is compared with the certified value. um is therefore estimated as 
0.5/√6 g/kg = 0.2 g/kg. 
=−=−=∆ g/kg 0.101.11CRMmm cc  1.1 g/kg 
=+=+=∆ g/kg  2222 8.02.0CRMm uuu  0.82 g/kg 
 
                                                 
[27] Trapmann S, Catalani P, Conneely P, Corbisier P, Gancberg D, Hannes E, Le Guern L, Kramer GN, 
Prokisch J, Robouch P, Schimmel H, Zeleny R, Pauwels J, Van den Eede G, Weighardt F, Mazzara M, Anklam 
E.(2002): The Certification of Reference Materials of Dry-Mixed Soya Powder with different Mass Fractions of 
Roundup ReadyTM  Soya, EC certification report EUR 20273 EN, ISBN 92-894-3725-1 
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The expanded uncertainty U∆  is 2 u∆  = 1.64 g/kg. This is larger than the difference ∆m 
between the certified and the measured value. The measured mean value is therefore not 
significantly different from the certified value and it can be concluded that the method has no 
bias. 
 
Uncertainty associated to the bias 
 
Any bias that may be associated with results is less than the uncertainty associated with bias. 
The standard uncertainty associated with this (ubiasr) is calculated as (Equation 10): 
22
0.10
100*8.0
6
5.11 ⎟⎠
⎞⎜⎝
⎛+=biasru = 9.3 %  
For 
n ...........6 
RSDR ....11.5 % 
uCRM .....  0.8 g/kg (U (k=2) = 1.6 g/kg) 
cCRM .....10.0 g/kg 
 
 
Calculation of the relative standard uncertainty 
 
The relative standard uncertainty (RSU) is calculated by combining RSDR with the ubiasr 
(Equation 11): 
 
%6.29%3.9%5.11 22 =+=RSU  
 
Evaluation of the measurement uncertainty 
 
Given that for the sample under investigation a RRS concentration of 15 g/kg has been 
measured, the standard measurement uncertainty is calculated according to Equation 12. As 
outlined in Section 2.2, sR associated with the lowest concentration can be used as an estimate 
of u0: 
 
( )22 %6.29/15%0269.0 ×+= kggu = 2.22 g/kg 
 
The value for u0 indicates already that it in this specific case it can be neglected. Hence, a 
direct calculation as outlined in the Nordtest report [13], following Equation 11 would be also 
possible: 
22 %5.11%3.9 +=  RSU = 14.79 %  
100
1*/15*%79.14 kgg=u = 2.22 g/kg 
 
The expanded uncertainty is calculated according to Equation 14 using a coverage factor of 2, 
which gives a level of confidence of approximately 95%: 
 
kggU /22.22×=  = 4.44 g/kg 
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Final step and reporting 
 
Given that for the sample under investigation a RRS concentration of 15 g/kg has been 
measured, the analytical result is reported as: 
 
'Roundup Ready® soybean = (15 ± 5) g/kg  
 
The expanded MU of relative 30 % is estimated from two independent analyses of real 
samples. A coverage factor of 2 was used, corresponding to a confidence level of 
approximately 95 %. The method applied proved to have no bias.' 
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ANNEX IV: Example of data handling operations potentially 
leading to uncertainty 
 
This list is by no means exhaustive, but it provides examples of which areas of data handling 
would benefit from increased standardisation, in order to reduce MU associated with a 
reported result. This list should raise awareness regarding the number of data handling aspects 
that can potentially give rise to MU. Additionally, although a number of current projects (e.g. 
the European sixth framework programme: Co-Extra [28]) are attempting to address the area 
of standardised data handling associated with GM results, there is little published literature 
relating to standardised guidelines on the subject [18, 29]. Thus, the following areas of data 
handling have been emphasised as potential factors that can account for MU in a reported 
result, but additional work needs to be conducted in the GM and real-time PCR fields in order 
to provide a standardised way to approach data handling. 
 
• A calibration curve is often constructed by measuring an instrument response according to 
a range of reference standards of known analyte concentration. The concentration of the 
analyte in the sample unknown is then evaluated based on this calibration curve. The 
construction of the calibration curve can affect the reliability of the result, and it needs to 
be considered if the curve should be produced using average values, or values from 
individual independent replicates. 
• The model used to construct the calibration curve is another important consideration. 
Typically, simple linear regression is used to produce the 'best fitting straight line' by 
minimising the sum of the squares of the deviations between the observed and expected 
values, given that a linear relationship exists. However, simple linear regression does not 
take into account the variability associated with each standard on the curve. Whilst in 
some experiments, linear regression is sufficient to give an acceptable response, it can bias 
results particularly when the variability of standards at the extreme ends of the calibration 
curve have different precision. This often occurs in routine GM analysis, and statistically, 
alternative models that take into account this heterogeneity of variance would be more 
suitable, for example weighted regression or censored regression. 
• The majority of reported results associated with GM quantification are based on using 
singleplex reactions within the laboratory. Singleplex reactions occur where the 
endogenous target analyte and the transgenic target analyte are assessed in separate wells 
or reaction vessels. However, an alternative approach is to use duplex reactions, where 
both endogenous and transgenic target analytes are assessed in the same reaction vessel. 
These two approaches have different characteristics associated with them in terms of use 
of resources and costs, and competition between reactions. However, the different reaction 
kinetics of the two approaches also dictate that the data can be evaluated according to a 
variety of methods, and one method may not be the most appropriate way to handle both 
sets of data. 
• The analyte concentration of sample unknowns are typically estimated based on the 
regression Equation associated with the calibration curve. Because of the nature of the 
                                                 
[28] Homepage of the European FP6 project Co-Extra – GM and non-GM supply chains: their co-existence and 
traceability: http://www.coextra.eu 
[29] Burns MJ, Nixon GJ, Foy CA, Harris N (2005): Standardisation of data from real-time quantitative PCR 
methods - evaluation of outliers and comparison of calibration curves, BMC Biotechnology, 5:31 doi: 
10.1186/1472-6750-5-31 
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PCR data set and the target analyte concentrations involved, this normally involves log 
transformation of data. A guidance document relating to how to evaluate sample 
unknowns would be beneficial, as taking individual independent replicates and then log 
transforming to give an average value, can give a very different result to averaging 
individual replicate values before log transformation. Additionally, the confidence level 
with which the final result is estimated will also differ according to what approach to 
transforming data has been adopted. 
• To help ensure that reaction conditions are similar between calibration curves, the slope of 
calibration curves are often compared. This gradient of the calibration curve is indicative 
of the efficiency of the PCR reaction, and for quality purposes it is also important that the 
PCR efficiency of standards used to produce a calibration curve is similar to the PCR 
efficiency associated with sample unknowns. This comparison has typically been 
conducted using a subjective visual assessment, but a statistical approach based on 
analysis of co-variance has been published that facilitates a more objective evaluation. 
The production of guidelines on how to facilitate this could impact upon the assessment of 
uncertainty in the reported result. 
• Individual PCR measurements in a data set that are thought to be outliers have the 
potential to introduce bias into a result. Standardised approaches to aid in successful 
identification of outlying values given the typical non-normal distribution of some values 
from real-time PCR, is only part of the issue associated with this problem. The second half 
of the problem involves recommending an approach to facilitate an objective decision on 
whether to include or exclude suspected outlying values, and this can impact greatly upon 
the final measurement. An objective approach using a combination of graphical and 
statistical techniques followed by identification and handling of outlying values using ISO 
guidelines, has been published [29]. 
 
The limited list of data handling approaches described above requires careful thought 
regarding the best statistical approaches to help interpret data. More work needs to be done at 
an international level in order to provide a standardised guidance document that would 
address all data handling approaches in this field. Production of such a standardised 'best 
practice guidelines' document will facilitate more accurate analysis of data arising from GM 
detection methods, and will contribute towards a greater understanding of the MU inherent 
within different data handling approaches. This will help provide a more meaningful and 
clearer interpretation of data arising from GM detection methods than is currently available. 
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ANNEX V: Data calculated on the bases of CRL collaborative trials 
 
Table 5: LOD, LOQ, U and estimated enforcement level based on collaborative trial data 
 
GM event
Matrix used for 
validation (DNA 
extraction 
method)
Measurement unit 
used during 
validation LOD [%] LOQ [%]
Expanded Uncertainty U 
(k  = 2) at labelling 
threshold (0.9 %) [%]
Estimated 
enforcement level 
[%]
Ring trial Roundup Ready (from Annex II)
RUR flour (CTAB) mass fraction GM 0.30 0.65 0.53 1.92
CRL ring trails including DNA extraction step
NK603 maize flour (CTAB) mass fraction GM 0.15 * 0.66 3.33
GA 21 maize flour (CTAB) mass fraction GM 0.36 * 0.58 2.46
MON 863 maize flour (CTAB) mass fraction GM 0.004 0.004 0.34 1.46
CRL ring trials without DNA extraction step
Bt 11 maize DNA copy number ratio 0.11 0.09 0.31 1.38
TC1507 maize DNA copy number ratio 0.10 0.10 0.42 1.67
T25 maize DNA copy number ratio 0.01 0.01 0.43 1.72
DAS 59122 maize DNA copy number ratio 0.25 0.22 0.25 1.21
RUR H7-1 sugar beet DNA copy number ratio 0.12 0.10 0.26 1.27
281-24-236 cotton DNA copy number ratio 0.14 0.13 0.31 1.35
3006-210-23 cotton DNA copy number ratio 0.15 0.15 0.40 1.62
LL62 rice DNA copy number ratio 0.13 0.11 0.25 1.24  
 
* RSU is bigger than RSUmax. The method is not good enough to fulfil the set criteria. Either the criteria have to be set less strict or the methods have to be improved. 
 
Furthermore it should be noted that reliable estimation of the enforcement levels requires the inclusion of the DNA extraction. Therefore 
estimated enforcement levels based on ring trials using extracted DNA may underestimate the uncertainty and hence the estimated enforcement 
level. 
The data provided here can be used if the method used in the laboratory is exactly the same. Details related to the method validation can be found 
on the homepage of the CRL for GMO food and feed [17]. 
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Figure 6: Enforcement level calculated for RRS collaborative trial given in Annex II, expressed in mass/mass %  
 
Using the data obtained during the method validation of RRS by collaborative trial (Annex II), it can be concluded that samples for which a GM 
concentration above 1.8 % (dashed line) is measured (using the RRS method) contain more that than the legal threshold of 0.9 % GM (red line). 
European Commission 
 
EUR 22756 EN – DG Joint Research Centre, Institute for Reference Materials and Measurements – 
Guidance Document on Measurement Uncertainty for GMO Testing Laboratories 
Authors: S. Trapmann, M. Burns, H. Broll, R. Macarthur, R. Wood, J. Zel 
Luxembourg: Office for Official Publications of the European Communities 
2007 – 41 pp. – 21.0 x 29.7 cm  
EUR - Scientific and Technical Research series; ISSN 1018-5593 
ISBN 978-92-79-05566-9 
 
 
 
Abstract 
This technical report outlines the technical issues related to the estimation of measurement uncertainty 
(MU) involved in the GMO sector. In particular it gives guidance to GMO testing laboratories how to 
estimate the analytical variability of quantitative analytical results obtained by real-time PCR. This 
guidance document has been written on request of the European Network of GMO Laboratories (ENGL) 
as a follow-up of a workshop on Measurement Uncertainty in the GMO sector organised by the Institute for 
Reference Materials and Measurements (IRMM), Geel, Belgium and held on 05.07.2005.   
It is recognised that in order to be able to judge if an analytical results exceeds a threshold; the MU must 
be estimated and reported together with the measurement result. Enforcement Authorities shall therefore 
estimate the MU associated with an analytical result and use it to decide whether an analytical result falls 
within the specification of food and feed control. The value obtained by subtracting the expanded 
uncertainty from the reported concentration is used to assess compliance. Only if this value is greater than 
the legal threshold, it is sure 'beyond reasonable doubt' that the sample concentration of the analyte is 
beyond what is permissible. 
Two selected approaches for the estimation of MU are presented in detail; references to alternative 
approaches are given. The first approach presented in detail is using data from collaborative trial in 
combination with in-house quality control data for the estimation of MU. Prerequisites for the use of such 
collaborative trial data are outlined. In case no suitable collaborative trial data are available, an alternative 
approach using data from within-laboratory samples for the estimation of MU is presented.  
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